Research

(iStock image)
April 3, 2024

Excess salt linked to heart disease deaths in low-income group: study

Excessive consumption of dietary sodium likely was responsible for up to 30% of cardiovascular disease-related deaths among mostly low-income participants in a large cohort study conducted by Vanderbilt University Medical Center.

By Bill Snyder
From left, Jennifer Pietenpol, PhD, Eric Farber-Eger, Lauren LeStourgeon, MPH, Luisella Spiga, PhD, and John Kuriyan, PhD.
April 2, 2024

VUMC research staff honored for excellence in the lab, clinic

Laboratory and administrative personnel at Vanderbilt University Medical Center were honored on March 29 for research excellence during the 20th annual Research Staff Awards Ceremony.

By Bill Snyder
(iStock image)
April 1, 2024

Cell-specific variations in gene regulation may be key to treating pulmonary fibrosis

An international research team co-led by Vanderbilt University Medical Center has revealed how variations in gene regulation in different cell types drive pulmonary fibrosis, a progressive respiratory disorder characterized by scarring and loss of functional lung tissue.

By Bill Snyder
March 28, 2024

VUMC team discovers antibodies that may prevent severe respiratory illness

Using a technique developed at Vanderbilt University Medical Center, researchers identified antibodies that are excellent leads as potential therapies for human parainfluenza virus 3, a leading cause of acute and potentially fatal respiratory illness.

By Bill Snyder
March 28, 2024

Teams to create one-stop resource for human pancreatic data to foster diabetes research

Leading investigators in diabetes, pancreas and islet biology, and computational biology have received $12.5 million in two five-year awards from the National Institutes of Health (NIH) to create the world’s first, integrated knowledge base of human-derived tissue- and cellular-level pancreatic information to support innovative, collaborative and reproducible research.

By Jill Clendening
March 28, 2024

Study identifies molecule as potential target for treating AML

While immune checkpoint inhibitors that target the PD-1 molecule on T-cells have proven to be effective with many cancers, these immunotherapies have not worked for acute myeloid leukemia (AML), but new research has identified a “cousin” molecule as a potential therapeutic target for AML. 

By Tom Wilemon
March 27, 2024

Higher genetic risk of obesity means working out harder for same results 

Study authors used activity, clinical and genetic data from the National Institutes of Health’s All of Us Research Program to explore the association of genetic risk of higher body mass index and the level of physical activity needed to reduce incident obesity. 
By Craig Boerner
March 26, 2024

Vanderbilt Prize winner’s lecture focused on the joy of discovery

During her Discovery Lecture on March 21, Professor Dame Frances Ashcroft, recipient of the 2023 Vanderbilt Prize in Biomedical Science, spoke on the joy science has given her.
By Bill Snyder
March 26, 2024

GRADE Study expands results of major NIH-sponsored comparative study of glucose lowering medications in Type 2 diabetes

The study, which included more than 5,000 volunteers with Type 2 diabetes from diverse racial and ethnic groups, compared the treatments insulin glargine, liraglutide, glimepiride and sitagliptin.
March 26, 2024

Beethoven’s genes reveal low predisposition for beat synchronization

What the exceptional composer's DNA tells us about genetics
By Craig Boerner
March 25, 2024

Brain atlas pinpoints vulnerabilities in ALS and dementia

By Paul Govern
March 25, 2024

VUMC team finds potential treatment for kidney fibrosis

By Bill Snyder
March 12, 2024

Genetic Counseling Research Symposium debuts on April 5

The Master of Genetic Counseling degree program at Vanderbilt University School of Medicine will hold its first Genetic Counseling Research Symposium April 5 from 8 a.m. to 6 p.m. in room 202, Light Hall.
By Bill Snyder
1 … 13 14 15 16 17 … 126